11
12
de Vries, Sieta T., Denig, Petra, Ekhart, Corine, Burgers, Jako S., Eefstra, Nanno K., Mol, Peter G. M., van Puijenbroek, Eugene P.
Veröffentlicht in: de Vries , S T , Denig , P , Ekhart , C , Burgers , J S , Eefstra , N K , Mol , P G M & van Puijenbroek , E P 2019 , ' Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands : An explorative observational study ' , British Journal of Clinical Pharmacology , vol. 85 , no. 7 , pp. 1507-1515 . https://doi.org/10.1111/bcp.13923;
2019
Veröffentlicht in: de Vries , S T , Denig , P , Ekhart , C , Burgers , J S , Eefstra , N K , Mol , P G M & van Puijenbroek , E P 2019 , ' Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands : An explorative observational study ' , British Journal of Clinical Pharmacology , vol. 85 , no. 7 , pp. 1507-1515 . https://doi.org/10.1111/bcp.13923;
2019
13
14
Arnardottir, Arna H., Haaijer-Ruskamp, Flora M., Straus, Sabine M. J., Eichler, Hans-Georg, de Graeff, Pieter A., Mol, Peter G. M.
Veröffentlicht in: Arnardottir , A H , Haaijer-Ruskamp , F M , Straus , S M J , Eichler , H-G , de Graeff , P A & Mol , P G M 2011 , ' Additional safety risk to exceptionally approved drugs in Europe? ' , British Journal of Clinical Pharmacology , vol. 72 , no. 3 , pp. 490-499 . https://doi.org/10.1111/j.1365-2125.2011.03995.x;
2011
Veröffentlicht in: Arnardottir , A H , Haaijer-Ruskamp , F M , Straus , S M J , Eichler , H-G , de Graeff , P A & Mol , P G M 2011 , ' Additional safety risk to exceptionally approved drugs in Europe? ' , British Journal of Clinical Pharmacology , vol. 72 , no. 3 , pp. 490-499 . https://doi.org/10.1111/j.1365-2125.2011.03995.x;
2011
15
Zhou, Guiling, de Vos, Stijn, Schuiling-Veninga, Catharina, Bos, Jens, Oude Rengerink, Katrien, Pasmooij, Marjon, Mol, Peter G. M., de Bock, G H, Hak, Eelko
Veröffentlicht in: Zhou , G , de Vos , S , Schuiling-Veninga , C , Bos , J , Oude Rengerink , K , Pasmooij , M , Mol , P G M , de Bock , G H & Hak , E 2023 , ' Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands : An Interrupted Time-Series Analysis ' , Clinical epidemiology , vol. 15 , pp. 923-937 . https://doi.org/10.2147/CLEP.S418069;
2023
Veröffentlicht in: Zhou , G , de Vos , S , Schuiling-Veninga , C , Bos , J , Oude Rengerink , K , Pasmooij , M , Mol , P G M , de Bock , G H & Hak , E 2023 , ' Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands : An Interrupted Time-Series Analysis ' , Clinical epidemiology , vol. 15 , pp. 923-937 . https://doi.org/10.2147/CLEP.S418069;
2023
16
de Vries, Sieta T., van der Sar, Maartje J. M., Cupelli, Amelia, Baldelli, Ilaria, Coleman, Anna Marie, Montero, Dolores, Sipic, Ivana, Andric, Adriana, Wennberg, Annika, Ahlqvist-Rastad, Jane, Denig, Petra, Mol, Peter G. M.
Veröffentlicht in: de Vries , S T , van der Sar , M J M , Cupelli , A , Baldelli , I , Coleman , A M , Montero , D , Sipic , I , Andric , A , Wennberg , A , Ahlqvist-Rastad , J , Denig , P , Mol , P G M & SCOPE Work Package 6 2017 , ' Communication on Safety of Medicines in Europe : Current Practices and General Practitioners' Awareness and Preferences ' , Drug Safety , vol. 40 , no. 8 , pp. 729-742 . https://doi.org/10.1007/s40264-017-0535-0;
2017
Veröffentlicht in: de Vries , S T , van der Sar , M J M , Cupelli , A , Baldelli , I , Coleman , A M , Montero , D , Sipic , I , Andric , A , Wennberg , A , Ahlqvist-Rastad , J , Denig , P , Mol , P G M & SCOPE Work Package 6 2017 , ' Communication on Safety of Medicines in Europe : Current Practices and General Practitioners' Awareness and Preferences ' , Drug Safety , vol. 40 , no. 8 , pp. 729-742 . https://doi.org/10.1007/s40264-017-0535-0;
2017
17
de Vries, Sieta T., Denig, Petra, Andrić, Adriana, Dimov Di Giusti, Marina, Ptaszynska-Neophytou, Alicia, Härmark, Linda, Mol, Peter G. M., the IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package
Veröffentlicht in: de Vries , S T , Denig , P , Andrić , A , Dimov Di Giusti , M , Ptaszynska-Neophytou , A , Härmark , L , Mol , P G M & the IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 2021 , ' Motives to Report Adverse Drug Reactions to the National Agency : A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK ' , Drug Safety . https://doi.org/10.1007/s40264-021-01098-4;
2021
Veröffentlicht in: de Vries , S T , Denig , P , Andrić , A , Dimov Di Giusti , M , Ptaszynska-Neophytou , A , Härmark , L , Mol , P G M & the IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 2021 , ' Motives to Report Adverse Drug Reactions to the National Agency : A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK ' , Drug Safety . https://doi.org/10.1007/s40264-021-01098-4;
2021